About Brightbox Quantitation
Brightbox Quantitation is a company based in San Mateo (United States) founded in 2019 was acquired by Calibre Scientific in January 2022. Brightbox Quantitation operates in a competitive market with competitors including ArcherDX, Neogen, Parse Biosciences, Qiagen and Biofidelity, among others.
- Headquarter San Mateo, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Calibre Scientific
(Jan 12, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Brightbox Quantitation
Detailed funding history for Brightbox Quantitation
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Brightbox Quantitation
Brightbox Quantitation has secured backing from 1 investor. Prominent investors backing the company include Calibre Scientific.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of contract based research, manufacturing, distribution and other services for biopharma sector
|
Locked | Locked | Locked |
Investor details for Brightbox Quantitation
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Brightbox Quantitation
Investment portfolio details for Brightbox Quantitation
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Brightbox Quantitation
Detailed financials for Brightbox Quantitation
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Brightbox Quantitation Comparisons
Peer comparison for Brightbox Quantitation
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Brightbox Quantitation
Brightbox Quantitation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ArcherDX, Neogen, Parse Biosciences, Qiagen and Biofidelity, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing
|
|
| Locked | Locked | Locked |
RNA-sequencing transcriptome kits for health data analysis are developed.
|
|
| Locked | Locked | Locked |
Products and reagents for molecular diagnostic assays are supplied.
|
|
| Locked | Locked | Locked |
Molecular diagnostic assays are developed for target DNA sequence detection.
|
|
| Locked | Locked | Locked |
Proprietary reagents for single-cell genetic analysis are developed.
|
Detailed competitors of Brightbox Quantitation
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Brightbox Quantitation
Complete news archive for Brightbox Quantitation
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Brightbox Quantitation
Brightbox Quantitation was founded in 2019.
Brightbox Quantitation is headquartered in San Mateo, United States. It is registered at San Mateo, California, United States.
Brightbox Quantitation was founded in 2019 and is based in San Mateo, United States. Operations focus on the biotechnology sector, where proprietary assay kits and reagents are produced and distributed for the detection and quantification of DNA or RNA NGS library molecules. An assay mix is included to identify sequenceable fragments, supporting rapid analysis in molecular biology applications.
Brightbox Quantitation's top competitors include Neogen, Qiagen and Parse Biosciences.
Brightbox Quantitation has 1 investor. Key investors include Calibre Scientific.